AstraZeneca will expand the its global R&D hub in Mississauga. This $820 million investment underscores Ontario ’s growing ...

AstraZeneca invests $570 million in Canada, expands facilities, and boosts R&D efforts, aiming to deliver 20 new medicines ...

AstraZeneca (NASDAQ:AZN), a global pharmaceutical firm, has announced a C$820 million (US$570 million) investment in Canada, ...

Cambridge headquartered global pharma company AstraZeneca is investing C$820 million (US$570m) in Canada, creating more than ...

“As the company continues to pursue a footprint of more than 2,000 jobs in Mississauga and Peel Region, Ontario’s world-class ...

AstraZeneca said it has created more than 1,200 jobs and invested more than $1.3-billion CAD in Canada since 2023. The ...

Invest Ontario is partnering with AstraZeneca (AZN) to expand the company’s global R&D hub in Mississauga. This C$820M investment ...

AstraZeneca plans C$820 million investment in Canada to advance growing global hub and clinical delivery: Mississauga, Ontario Saturday, January 25, 2025, 09:00 Hrs [IST] AstraZen ...

Spreading its geographic wings further, in the face of ongoing difficulties in China, UK pharma major AstraZeneca has ...

AstraZeneca will invest 820 million Canadian dollars, equivalent to $570.3 million, to facilitate a move to a larger office in the Toronto metro area. The Anglo-Swedish pharmaceutical giant said ...

New jobs are coming to a Mississauga company. Officials gathered at the Mississauga-based biopharmaceutical company ...

AstraZeneca, a global pharmaceutical company focused on developing life changing medicines, today announced a C$820 million (US$570m) investment in Canada, creating more than 700 high-skilled jobs, ...